Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-extubational loading dose of caffeine-citrate in preterm neonates
2024-519041-29-02Phase 4Authorised
- Sponsor
- Semmelweis University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of caffeine in extubation failure, bronchopulmonary dysplasia (BPD) and apnea of prematurity (AOP), sponsored by Semmelweis University. Primary endpoint: Reintubation. Planned start Jan 2025; status: authorised.
02
Drugs
caffeine
03
Conditions
extubation failurebronchopulmonary dysplasia (BPD)apnea of prematurity (AOP)
Beyond the preview
Go deeper on 2024-519041-29-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519041-29-02.